Cromos Pharma, where the patients are

Awards & Advancement

Alexander Poltorak joins Spherix board of directors

Monday, November 4, 2013 12:54 PM

Spherix, an intellectual property development company committed to the fostering and monetization of intellectual property, has appointed Alexander Poltorak to Spherix's board of directors.

More... »

CRF Health eCOA webinar series

Richard Segiel, Jr. joins Almac as vice president of U.S. business development

Thursday, October 31, 2013 10:00 AM

Richard Segiel, Jr. has joined Almac’s clinical services business unit as vice president of business development for the U.S. He will focus on developing new business, maintaining existing business and developing partnerships.

More... »

Quintiles named a Best Multinational Workplace for third consecutive year

Thursday, October 31, 2013 09:00 AM

Quintiles has been recognized as one of the World’s Best Multinational Workplaces by Great Place to Work, ranking 18th on the 2013 list. 

More... »

ShangPharma appoints Arthur Taveras president and CSO

Monday, October 28, 2013 12:08 PM

CRO ShangPharma has announced that Dr. Arthur Taveras will join the company as president and chief scientific officer. Taveras brings pharmaceutical leadership and technical experience in drug discovery, chemistry R&D and pharmaceutical development having worked as a pharmaceutical and biotech executive during his 24 year career.

More... »

IDDI simplifies collaboration, switches to Veeva Systems’ Vault eTMF Solution

Wednesday, October 23, 2013 04:31 PM

International Drug Development Institute (IDDI), an international functional CRO headquartered in Belgium, replaced its mix of a paper-based trial master file (TMF) and e-rooms with Veeva Systems’ cloud-based Vault eTMF solution, part of Veeva’s Development Suite. As a CRO that collects, analyses and reports all data from international phase I through IV clinical trials for sponsors throughout the U.S., Europe and Asia, IDDI wanted a single, centralized system to streamline auditing and collaboration. After evaluating five systems, IDDI chose Vault eTMF for its document tracking capabilities and globally accessible cloud platform.

More... »

BioDelivery Sciences appoints Ernest De Paolantonio CFO

Tuesday, October 22, 2013 09:00 AM

BioDelivery Sciences International, a specialty pharmaceutical company, has appointed Ernest R. De Paolantonio chief financial officer and corporate secretary.

More... »

Celladon appoints Michael Narachi chairman of the board

Friday, October 18, 2013 01:15 PM

Celladon, a clinical-stage biotechnology company focused on developing novel therapies by applying its leadership position in the field of SERCA enzymes, has appointed Michael Narachi chairman of the board of directors.

More... »

Immune Pharmaceuticals changes board of directors

Thursday, October 17, 2013 11:01 AM

Immune Pharmaceuticals has announced that Rene Lerer, M.D., executive chairman of Magellan Health Services, and Daniel Kazado, senior advisor to Melini Capital, have joined the company's board of directors. Lerer and Kazado replace Pierre Albouy and Herve de Kergrohen, who have resigned from the board but will continue as strategic advisors to the company.  The board will continue to consist of seven members.

More... »

Greenphire appoints Alex Livingstone senior director of business development

Tuesday, October 15, 2013 09:29 AM

Greenphire, a provider of payment technologies for the clinical trials industry, has appointed Alex Livingstone senior director of business development in Europe. Livingstone brings more than 12 years of eClinical software, pharmaceutical and biotechnology industry experience to the company, in a move designed to help Greenphire extend its footprint in European markets.

More... »

Neurotrope hires Robert Weinstein as EVP, CFO

Tuesday, October 8, 2013 08:00 AM

Neurotrope (formerly BlueFlash Communications), a Nevada-based company, has hired Robert Weinstein to be its executive vice president and chief financial officer.  Weinstein had been the acting chief financial officer, as a consultant, since May and was instrumental in executing the company's private financings and reverse merger, which both closed in August.

More... »

CenterWatch Drugs in Clinical Trials



Browse by:


April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly


Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly


Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.


Featured Jobs